Lynparza is a poly (ADP-ribose) polymerase (PARP) inhibitor indicated:
• for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, who are in a complete or partial response to platinum-based chemotherapy. • for the treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm) advanced ovarian cancer who have been treated with three or more prior lines of chemotherapy. Select patients for therapy based on an FDA-approved companion diagnostic for Lynparza.
• in patients with deleterious or suspected deleterious gBRCAm, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have previously been treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting. Patients with hormone receptor (HR)-positive breast cancer should have been treated with a prior endocrine therapy or be considered inappropriate for endocrine treatment. Select patients for therapy based on an FDA-approved companion diagnostic for Lynparza.
Olaparib, sold under the brand name Lynparza, is a medication for the maintenance treatment of BRCA-mutated advanced ovarian cancer in adults. It is a PARP inhibitor, inhibiting poly ADP ribose polymerase (PARP), an enzyme involved in DNA repair. It acts against cancers in people with hereditary BRCA1 or BRCA2 mutations, which include some ovarian, breast, and prostate cancers.
Please contact at +91 9910645395 or send your enquiry at info@cancermedicinesnetwork to find the price of LYNPARZA® (olaparib) tablets, for oral use in Vietnam, Philippines and Ireland. We take guarantee of quality and delivery as per the buyer’s requirements.
Dear Rakesh and Colleagues,
We are very happy to let you know that, just after three weeks, there is no trace of the sickness anymore: your medicine did the job very well!
We will always remember with great pleasure your warm welcoming in Delhi! We would like to thank you very much and wish you all the best. In the coming future we will be delighted to suggest your company to other patients.
Sir, As a first time buyer of an iported drug I'm imressed with your company in procurement of the drug from Canada through the shipping time of 11 to 12 days is quite long to wait. Mr Rajesh Kanan your coordinator has been very helpful and cooperative to my many queries. He is always responsive to my SMS, Whatsapp, email and phone calls. Hoping that the good trend will continue in the future. There is some miscommunications with the TNT courier with my first delivery. Hope that will be solved in the second delivery.
To buy LYNPARZA (olaparib) tablets in India, request you to send your details via query form or you can call or WhatsApp (+91) 9910645395 or send mail to email@example.com to know the best price. We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
Yes, Verve Biosciences can assist in the delivery of LYNPARZA (olaparib) tablets, doctor prescribed medicine. The Order Will Be Confirmed Only After The Receipt Of Valid prescription of Doctor and Import permit if applicable.
Verve Biosciences have exported LYNPARZA (olaparib) tablets in China, UAE, Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.